LGND - Ligand Pharmaceuticals Incorporated

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts4455
Avg. Estimate0.550.693.263.77
Low Estimate0.380.673.23.15
High Estimate0.650.73.44.16
Year Ago EPS2.591.327.153.26
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts4455
Avg. Estimate21.01M25.24M119.98M127.15M
Low Estimate17.28M24.4M117.7M124M
High Estimate23.94M26.22M124M129.4M
Year Ago Sales90.04MN/A251.45M119.98M
Sales Growth (year/est)-76.70%N/A-52.30%6.00%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.2.341.031.221.02
EPS Actual2.591.321.71.16
Difference0.250.290.480.14
Surprise %10.70%28.20%39.30%13.70%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate0.550.693.263.77
7 Days Ago0.550.693.263.77
30 Days Ago0.540.683.83.88
60 Days Ago0.620.764.163.88
90 Days Ago1.211.355.342.99
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesLGNDIndustrySectorS&P 500
Current Qtr.-78.80%N/AN/A0.01
Next Qtr.-47.70%N/AN/A0.03
Current Year-54.40%N/AN/A0.04
Next Year15.60%N/AN/A0.10
Next 5 Years (per annum)10.20%N/AN/A0.08
Past 5 Years (per annum)40.29%N/AN/AN/A